EQL PHARMA AB (7JK) — Working Capital to Net Assets Ratio
EQL PHARMA AB (7JK) has a Working Capital to Net Assets ratio of 72.5% as of March 2026. Working capital of €193.64 Million (current assets of €403.87 Million minus current liabilities of €210.23 Million) is measured against net assets of €267.06 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 7JK days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
EQL PHARMA AB Working Capital to Net Assets (2022–2026)
This chart shows how EQL PHARMA AB's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the ratio stands at 72.5%, reflecting working capital of €193.64 Million against net assets of €267.06 Million EUR. For the complete balance sheet picture, see EQL PHARMA AB total assets.
Annual Working Capital to Net Assets for EQL PHARMA AB (2022–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for EQL PHARMA AB from 2022 to 2026, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read EQL PHARMA AB balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 72.5% | €193.64 Million | €267.06 Million | €403.87 Million | €210.23 Million | ▼ -8.6 pp |
| 2025 | 81.1% | €179.23 Million | €221.03 Million | €400.25 Million | €221.02 Million | ▲ +61.0 pp |
| 2024 | 20.1% | €35.72 Million | €177.73 Million | €197.77 Million | €162.05 Million | ▼ -12.2 pp |
| 2023 | 32.3% | €50.04 Million | €154.75 Million | €167.23 Million | €117.19 Million | ▲ +12.4 pp |
| 2022 | 20.0% | €24.70 Million | €123.63 Million | €123.45 Million | €98.76 Million | — |